SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending as traders discuss Trump's potential executive action to reclassify marijuana, sparking hope for the cannabis sector. The community is debating the implications of rescheduling, potential short squeezes, and comparing TLRY to other cannabis stocks. Some are also expressing skepticism, citing past disappointments and the need for concrete action.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom's stock is experiencing volatility despite strong earnings, with analysts' target prices driving much of the current discussion. While the company beat expectations and offered positive guidance, some investors are taking profits, and others are concerned about future growth potential in non-AI sectors. The community is debating the sustainability of Broadcom's valuation and the impact of AI revenue projections.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members highlight its roots in cannabis culture and its presence on the Solana blockchain. Many are drawn to its positioning as a 'culture coin' with a focus on creativity and community building. Comparisons to Bitcoin are frequent, with the community emphasizing a vision of going 'way higher'.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors anticipate its Autonomy and AI Day, where the company is expected to reveal advancements in its self-driving technology and AI capabilities, with community chatter focusing on potential partnerships and the impact on competition with Tesla. Discussions also include analyst target price updates and debate over Rivian's valuation as a tech versus automotive company, alongside concerns about cash flow and production costs.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending after a Q3 earnings beat, raised full-year guidance, a CEO succession plan, and a buyback authorization, leading to analyst target price revisions. The community is discussing the potential for analyst upgrades and whether the stock can hold its gains amidst a challenging year. Some traders are pointing to strong execution, long-term visibility, and growth in China as reasons for renewed confidence.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is gaining significant traction, fueled by community enthusiasm and its association with the Ethereum ecosystem. Discussions highlight its potential as a leading meme token and a beneficiary of renewed interest in ETH, with some even suggesting it could be the next PEPE. The community emphasizes strong fundamentals, a compelling narrative, and increasing accumulation from experienced traders.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as the aerospace sector gains momentum, potentially fueled by speculation around a SpaceX IPO and renewed interest in space infrastructure. The community is discussing the company's growth potential, upcoming launches, and Neutron rocket development, with some analysts projecting significant upside. Positive sentiment is also emerging related to AI data centers in space, potentially creating further opportunities for Rocket Lab.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending due to anticipation surrounding an upcoming presentation and speculation about potential news, possibly at the SABCS conference. Community members are focused on the high short borrow rate and the possibility of a short squeeze, with some expressing FOMO and discussing technical indicators. The overall sentiment suggests a belief in the company's long-term potential, particularly regarding its breast cancer treatment.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to significant intraday volatility, with community members actively discussing a potential short squeeze and the impact of a recent conference. The stock's price swings are also influenced by its low float and sector momentum, particularly related to Bitcoin's movements. Some traders are wary of a potential offering and the company's compliance with listing requirements.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending as the community discusses recent investments in Ukrainian drone technology and potential benefits from increased defense spending. Bullish sentiment is fueled by the company's growing presence in the drone and counter-drone space, with speculation around upcoming announcements and price target increases. Traders are actively monitoring key price levels for breakout opportunities, and whether it could trigger a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kristian Reich Sells 130,000 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) insider Kristian Reich sold 130,000 shares of the company's stock in a transaction dated Monday, December 8th. The shares were sold at an...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Sells $1,960,400.00 in Stock

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 130,000 shares of the stock in a transaction dated Monday, December 8th. The stock was sold at an average...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Da Silva Jorge Santos Sells 70,000 Shares

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 70,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 9th. The stock was...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Kristian Reich Sells 72,908 Shares

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) insider Kristian Reich sold 72,908 shares of the stock in a transaction dated Tuesday, December 9th. The shares were sold at an average...

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025 DEADLINE NEXT WEEK: Berger Montague Advises MoonLake...

MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

Global plaintiffs' rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) is rapidly...

MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

MLTX 6-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman MLTX 6-DAY...

Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX Investors in MoonLake Immunotherapeutics Should Contact Levi...

Marshall Wace LLP Sells 111,706 Shares of MoonLake Immunotherapeutics $MLTX

Marshall Wace LLP reduced its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) by 17.4% in the second quarter, according to the company in its most recent 13F filing with...

Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX)

Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX) Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$14.07
Prev Close	$14.61
Open	$14.44
Dividend Yield	0.00%
50-Day Moving Average	$11.36
Beta	0.51
Avg. Volume	2.21M
PE Ratio	-4.23

52-Week High	$62.75
52-Week Low	$5.95
Market Capitalization	$1.04B
EPS (Annual)	-$1.89
Price to Book	3.10
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MLTX
MoonLake Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLTX News

MLTXMoonLake Immunotherapeutics